Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBaillie Gifford Shin Nippon PLC Regulatory News (BGS)

Share Price Information for Baillie Gifford Shin Nippon PLC (BGS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 113.00
Bid: 112.80
Ask: 113.00
Change: 0.20 (0.18%)
Spread: 0.20 (0.177%)
Open: 108.80
High: 113.20
Low: 108.80
Prev. Close: 112.80
BGS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

29 Oct 2021 13:40

RNS Number : 7698Q
Baillie Gifford Shin Nippon PLC
29 October 2021
 

Baillie Gifford Shin Nippon PLC (BGS)

Appointment of Directors

Legal Entity Identifier: X5XCIPCJQCSUF8H1FU83

Regulated Information Classification Additional regulated information required to be disclosed under applicable law.

 

The Board is pleased to announce the appointment of Ms Claire Finn and Ms Abigail Rotheroe as non-executive Directors of the Company. Ms Claire Finn will be a non-executive Director of the Company with effect from 1 November 2021 and Ms Abigail Rotheroe with effect from 1 March 2022.

 

Claire began her career in Japan in 1995 before moving back to the UK in 1999. She worked for Tokyo Mitsubishi Bank in London from 1999 to 2001. In 2001 she joined Henderson Global Investors undertaking roles in client service and product development. In 2005 Claire joined Merrill Lynch Investment Mangers (MLIM) as Vice President of Product Development. MLIM was subsequently bought by BlackRock and Claire moved into the distribution team, rising to the position of Managing Director of Defined Contributions, Unit Linked and Platforms. Claire left BlackRock in 2018 and transitioned to a portfolio career in 2019. She is now a director of The Law Debenture Corporation PLC, Octopus Apollo VCT PLC, Artemis Fund Managers Limited and Sparrows Capital Limited.

 

Abigail is a CFA® charterholder whose investment career began at Schroder Capital Management in 1987 as an analyst on the Japanese desk. She worked in Hong Kong for Schroders and then HSBC, managing specialist Asia/Pacific equity portfolios for Japanese clients. On her return to London in 1994, she joined Threadneedle Investments with responsibility for the Threadneedle Asia Growth Fund, Threadneedle Asia and Pacific inc. Japan Growth Fund and the TIML India Fund. Since 2013 Abigail has been at the forefront of social and impact investing and has published broadly on the subject. She is the Investment Director of Snowball Impact Management, an asset manager that invests responsibly to achieve impact alongside financial returns.

 

Neil Donaldson, Chairman of Baillie Gifford Shin Nippon commented:

 

"My fellow Directors and I are delighted to welcome Claire and Abigail to the Board. They have extensive and relevant business and finance experience and their appointments will maintain the Board's depth and breadth."

 

The Board engaged with the relevant shareholders following the significant number of votes against the re-appointment of Mr Donaldson at the Annual General Meeting. The shareholder concerns related to board composition and were considered in the board succession planning culminating in these appointments.

 

The appointments of both Ms Claire Finn and Ms Abigail Rotheroe as directors fall to be ratified by shareholders at the Annual General Meeting of the Company to be held in 2022.

 

There is no further information required to be disclosed under section 9.6.13 of the Listing Rules.

 

 

Baillie Gifford & Co Limited

Managers and Secretaries

29 October 2021

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAPPGMWUUPGGPB
Date   Source Headline
26th Jul 20234:57 pmRNSTransaction in Own Shares
26th Jul 202312:28 pmRNSNet Asset Value(s)
25th Jul 202311:53 amRNSNet Asset Value(s)
24th Jul 202311:43 amRNSNet Asset Value(s)
21st Jul 20231:05 pmRNSNet Asset Value(s)
20th Jul 202312:14 pmRNSNet Asset Value(s)
19th Jul 202312:05 pmRNSNet Asset Value(s)
18th Jul 20234:57 pmRNSTransaction in Own Shares
18th Jul 202312:25 pmRNSNet Asset Value(s)
18th Jul 202310:38 amRNSHolding(s) in Company
17th Jul 202311:13 amRNSNet Asset Value(s)
14th Jul 20235:20 pmRNSTransaction in Own Shares
14th Jul 202311:46 amRNSNet Asset Value(s)
13th Jul 202310:58 amRNSNet Asset Value(s)
12th Jul 202310:51 amRNSNet Asset Value(s)
11th Jul 20234:59 pmRNSTransaction in Own Shares
11th Jul 202310:48 amRNSNet Asset Value(s)
10th Jul 202312:29 pmRNSNet Asset Value(s)
7th Jul 202311:12 amRNSNet Asset Value(s)
6th Jul 202310:59 amRNSNet Asset Value(s)
5th Jul 202310:50 amRNSNet Asset Value(s)
4th Jul 20234:56 pmRNSTransaction in Own Shares
4th Jul 202310:40 amRNSNet Asset Value(s)
3rd Jul 20234:58 pmRNSTransaction in Own Shares
3rd Jul 202312:45 pmRNSTotal Voting Rights
3rd Jul 202312:13 pmRNSNet Asset Value(s)
30th Jun 202311:45 amRNSNet Asset Value(s)
29th Jun 202311:12 amRNSNet Asset Value(s)
28th Jun 202311:10 amRNSNet Asset Value(s)
27th Jun 202311:28 amRNSNet Asset Value(s)
26th Jun 202311:15 amRNSNet Asset Value(s)
23rd Jun 202311:18 amRNSNet Asset Value(s)
22nd Jun 202312:25 pmRNSNet Asset Value(s)
21st Jun 202311:57 amRNSNet Asset Value(s)
21st Jun 202310:10 amRNSBlock listing Interim Review
20th Jun 20234:56 pmRNSTransaction in Own Shares
20th Jun 202311:01 amRNSNet Asset Value(s)
19th Jun 202312:33 pmRNSNet Asset Value(s)
16th Jun 202310:47 amRNSNet Asset Value(s)
15th Jun 20235:07 pmRNSTransaction in Own Shares
15th Jun 202312:02 pmRNSNet Asset Value(s)
14th Jun 202311:54 amRNSNet Asset Value(s)
13th Jun 202311:57 amRNSNet Asset Value(s)
13th Jun 202310:17 amRNSDirector/PDMR Shareholding
12th Jun 202312:26 pmRNSNet Asset Value(s)
9th Jun 202310:30 amRNSNet Asset Value(s)
8th Jun 20235:14 pmRNSTransaction in Own Shares
8th Jun 202311:24 amRNSNet Asset Value(s)
7th Jun 20235:13 pmRNSTransaction in Own Shares
7th Jun 202311:06 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.